[1] 汪晋,马金良.肝癌预后相关影响因素.中国普通外科杂志,2015,24:270-274.
[2] 丛文铭.肝癌规范化病理诊断.中国实用外科杂志,2016,36:686-687,691.
[3] 邵剑锋,周洪益,周志毅,等.肿瘤相关巨噬细胞浸润、肿瘤微血管密度和血管内皮生长因子在膀胱癌中的表达.江苏医药,2015,41:2562-2564.
[4] 周丽莉,张建刚,王霞,等.经直肠超声造影定量分析对前列腺癌的鉴别与诊断价值探讨.中国肿瘤临床与康复,2015,22:546-548.
[5] 包中涛,古立娟,刘景丰,等.声脉冲辐射力技术鉴别诊断肝脏局灶性病变. 中华肝脏病杂志,2016,24:123-126.
[6] Li HM. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine. Chin J Integr Med,2016,22:163-167.
[7] Nadkarni NJ, Geest KD, Neff T, et al. Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer. Cancer Lett, 2013, 331:99-104.
[8] Numata K, Tanaka K. Liver cancer: progress in diagnosis and treatments. Topics: V. Progress in diagnosis of liver cancer; 1. Diagnosis of hepatocellular carcinoma by ultrasonography. Nihon Naika Gakkai Zasshi, 2014,103:44-54.
[9] 徐娟,赵晔,李俊芝.原发性肝癌超声造影诊断的特征性声像图表现.肝脏,2016,21:441-443.
[10] 李真真,王绮,张延瑞,等. 复发性肝细胞性小肝癌超声造影强化模式量化分析. 实用医学杂志, 2016, 32:774-777. |
